Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 147Breast Neoplasms 108Lung Neoplasms 92Carcinoma, Non-Small-Cell Lung 77Neoplasm Metastasis 68Glioblastoma 68Brain Neoplasms 64Glioma 59Pancreatic Neoplasms 45Carcinoma, Renal Cell 43Multiple Myeloma 41Squamous Cell Carcinoma of Head and Neck 39Colorectal Neoplasms 38Lymphoma, Large B-Cell, Diffuse 37Neoplasms 34Melanoma 32Lymphoma 32Carcinoma, Hepatocellular 32Urinary Bladder Neoplasms 31Ovarian Neoplasms 29Astrocytoma 28Sarcoma 25Oropharyngeal Neoplasms 24Lymphoma, Follicular 23Central Nervous System Neoplasms 23Rectal Neoplasms 22Uterine Cervical Neoplasms 21Triple Negative Breast Neoplasms 21Mouth Neoplasms 21Lymphoma, Non-Hodgkin 21

Interventions

Nutrition Assessment 2Collagenases 2upadacitinib 1tocilizumab 1acetaminophen, aspirin, caffeine drug combination 1Vaccines 1Transcutaneous Electric Nerve Stimulation 1Saline Solution 1Resistance Training 1Radiotherapy 1Omeprazole 1Naproxen 1Melphalan 1Magnetic Resonance Spectroscopy 1Lysine Acetyltransferase 5 1Holistic Health 1Herpes Zoster Vaccine 1Febuxostat 1Exergaming 1Exercise Therapy 1Colchicine 1Blood Specimen Collection 1Allopurinol 1Adalimumab 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Arthritis × Magnetic Resonance Spectroscopy × Clear all
NCT07284563 2025-12-16

Ultralow Dose PET Imaging for 18F-NaF Uptake

Nuclear Imaging Institute

Phase 2 Recruiting
200 enrolled

Arthritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡